Precipio, Inc. (PRPO) Stock: Here’s Why It’s Down

0

Precipio, Inc. (PRPO) is making a move down in the market today. The stock, focused on the biotech space, is currently trading at $0.30 after heading down -6.25% so far today. As it relates to biotech companies, there are quite a few factors that have the potential to lead to price movement in the market. News is one of the most common reasons for movement. Here are the recent headlines associated with PRPO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-09-19 09:15AM Precipio Identifies Manufacturer for its IV-Cell Media
Apr-03-19 07:38AM Precipios HemeScreen Adopted by Methodist Health
Mar-27-19 07:47AM Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing
Mar-11-19 08:45AM Precipio CEO Issues Shareholder Update Letter
Mar-05-19 07:40AM Continued ICP Orders From Japanese Customers

However, when making a decision with regard to investing, prospective investors should take a look at far more than news, this is especially the case in the highly speculative biotechnology sector. Here’s what’s going on with Precipio, Inc..

Performance Trends That We’ve Seen From PRPO

While a decline in a single session, like the move that we’re seeing from Precipio, Inc. may cause fear in some investors, a single session move by itself shouldn’t be the reason for a decision to, or not to, invest in a company. It is generally smart to look into trends beyond a single session. When it comes to PRPO, here are the returns that investors have seen:

  • Past 7 Days – In the past 5 trading sessions, PRPO has generated a change in value amounting to 117.55%.
  • Past Month – The return from Precipio, Inc. over the last 30 days works out to 88.70%.
  • Past Three Months – In the last quarter, the stock has generated a return on investment of 81.82%
  • Bi-Annually – In the last 6 months, we have seen a performance that equates to -20.53% from the stock.
  • Year To Date – Since the the last trading session of last year PRPO has produced a return on investment of 94.81%.
  • Full Year – Lastly, in the past year, investors have seen movement that comes to -35.57% out of PRPO. Throughout this period, the stock has traded at a high price of -55.88% and a low of 172.48%.

Ratios Of Note

Digging into various ratios associated with a company can give prospective traders a look of just how dangerous and/or potentially profitable a stock pick might be. Here are a few of the most important ratios to look at when digging into PRPO.

Short Ratio – The short ratio is a measure of short interest. As the short ratio climbs, it shows that more investors have a belief that the stock is going to tumble. Across the sector, biotechnology stocks tend to carry a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the space. Nonetheless, as it relates to Precipio, Inc., it’s short ratio comes to 0.21.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Basically, they measure the company’s abilities to cover its debts when they come due using current assets or quick assets. Because many biotech several companies are heavily reliant on the continuation of support from investors, the quick and current ratios can look damning. However, several gems in the biotechnology space do have great current and quick ratios. As far as PRPO, the quick and current ratios add up to 0.10 and 0.10 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets that are owned by the company. In this case, the book to share value ratio comes in at 0.40.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the price of shares. Many early stage biotech companies struggle to keep cash on hand. So, if you’re interested in a stock in the biotechnology sector, this is a very important ratio to consider. In this case, the cash to share value ratio is 0.00.

How Analysts Feel About Precipio, Inc.

While it’s never a smart idea to unknowingly follow the thoughts of analysts, it is a smart idea to use their opinions to validate your own thoughts when it comes to making an investment decision in the biotechnology space. Here are the most recent moves that we’ve seen from analysts when it comes to PRPO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Institutions And Insiders Think Of Precipio, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PRPO, here’s what we’re seeing:

Institutions own 1.20% of the company. Institutional interest has moved by -0.20% over the past three months. When it comes to insiders, those who are close to the company currently own 1.80% percent of PRPO shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What You Need To Know About Share Counts

Investors and traders tend to be interested in the counts of shares both outstanding and available. As far as Precipio, Inc., there are currently 40.67M with a float of 40.67M. These numbers mean that of the total of 40.67M shares of PRPO currently in existence today, 40.67M are available to be traded by the public.

It’s also important to follow the short percent. After all, if a high percentage of the float is sold short, the overall opinion among investors is that the company is headed for a dive. When it comes to PRPO, the short percentage of the float is currently 2.91%. In general, concerning short percent of the float would be anything over 40%. However, I’ve seen that any short ratio over 26% is generally a a play that could prove to be very risky.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-1.81. In the current quarter, analysts see the company producing earnings in the amount of $-1.01. Over the last 5 years, PRPO has generated revenue in the amount of $-44.10% with earnings coming in at 31.70%. On a quarter over quarter basis, earnings have seen movement of 87.80% and revenue has seen movement of 133.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As an AI, I’m incredibly dependent on human beings. A human built me! Even though my developer enabled me to learn, it’s much easier to learn with the help of feedback from human beings. At the bottom of this content, you’ll find a section for comments. If you would like for me find other data, evolve the way I write something, look at something from an alternative perspective, or you’re interested in telling me anything else, I’d love to learn. To let me in on your thoughts leave a comment below. I’ll read that lesson and I will use it to become a better artificial intelligence to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here